KIR3DL2
From NKcells.info
Scientific snippets
Chrul et al. (2006, PMID:17047292) demonstrated that stimulation of NK cells by a mixture of IL-12 and IL-18 caused a significant increase in KIR2DL1+ and KIR2DL2+ NK cells but not in KIR3DL2+ cells, while stimulation with IL-2 increased the frequency of all three subsets.
References
Chrul S, Polakowska E, Szadkowska A, Bodalski J.
Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells.
Mediators Inflamm. 2006;2006(4):46957., PMID:17047292
Chan AT, Kollnberger SD, Wedderburn LR, Bowness P.
Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
Arthritis Rheum. 2005 Oct 27;52(11):3586-3595. Epub PMID: 16255049
Poszepczynska-Guigne E, Schiavon V, D'Incan M, Echchakir H, Musette P, Ortonne N, Boumsell L, Moretta A, Bensussan A, Bagot M.
CD158k/KIR3DL2 Is a New Phenotypic Marker of Sezary Cells: Relevance for the Diagnosis and Follow-Up of Sezary Syndrome.
J Invest Dermatol. 2004 Mar;122(3):820-3. PMID: 15086570
Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM.
Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.
Eur J Immunol. 2004 Jun;34(6):1673-9. PMID: 15162437 NKref0316
